This observations align with the initial publication on COMP expression in breast cancer, which determined that COMP expression by the cancer cells correlated with a worse prognosis for breast cancer patients and could serve as an independent survival prognostic marker [1]. This evidence concerns the gene COMP and breast carcinoma.